SECONDARY 1,3-THIAZOLE-5-YL SULFONAMIDE DERIVATIVES AND THEIR USE AS ANTIVIRAL AGENTS

Details for Australian Patent Application No. 2002354849 (hide)

Owner BAYER AKTIENGESELLSCHAFT

Inventors BENDER, Wolfgang; ECKENBERG, Peter; HANDKE, Gabriele; HENNINGER, Kerstin; JENSEN, Axel; KELDENICH, Jorg; SCHNEIDER, Udo; WEBER, Olaf; FISCHER, Rudiger; BETZ, Ulrich; HENDRIX, Martin; KLEYMANN, Gerald; SCHOHE-LOOP, Rudolf; BAUMEISTER, Judith

Pub. Number AU-A-2002354849

PCT Number PCT/EP02/06697

PCT Pub. Number WO2003/007946

Priority 101 31 128.1 28.06.01 DE

Filing date 18 June 2002

Wipo publication date 3 March 2003

International Classifications

A61K 031/426 - 1,3-Thiazoles

A61K 031/427 - not condensed and containing further heterocyclic rings

C07D 277/54 Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61P 031/22 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 101 31 128.1 28.06.01 DE

22 May 2003 Application Open to Public Inspection

  Published as AU-A-2002354849

18 March 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002354850-4-(benzylidene-amino)-3-(methylsulfany l)-4H-(1, 2, 4) triazin-5-one derivatives having a PDE-IV inhibiting and TNFantagonistic effect for the treatment of cardiac diseases and allergies

2002354848-Liquid formulation comprising Cetuximab and a fatty acid ester of polyoxyethylene sorbitan